Shrikant Tamhane, MD
Endocrinology, Diabetes & Metabolism · Columbus, OHNPI 1891040762
Payments from drug & device makers
Across 599 payments — averaging $91.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$37K
- Amgen$9K
- Boehringer Ingelheim$2K
- Lilly USA, LLC$808
- Novo Nordisk$751
- AstraZeneca$724
- plus $5K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 32 | $36,820 |
| Amgen(2 entities) | 84 | $9,152 |
| Boehringer Ingelheim | 42 | $1,760 |
| Lilly USA, LLC | 42 | $808 |
| Novo Nordisk | 55 | $751 |
| AstraZeneca(2 entities) | 39 | $724 |
| Abbott | 32 | $642 |
| Sanofi-aventis U.S. LLC | 42 | $589 |
| Corcept Therapeutics | 34 | $516 |
| Xeris Pharmaceuticals, Inc. | 17 | $325 |
| Insulet Corporation | 8 | $315 |
| Dexcom, Inc. | 17 | $295 |
| Bayer | 17 | $294 |
| Medtronic(2 entities) | 13 | $223 |
| Tandem Diabetes Care, Inc. | 11 | $196 |
| Valeritas, Inc. | 39 | $182 |
| Kyowa Kirin, Inc. | 7 | $178 |
| Mannkind Corporation | 10 | $161 |
| Merck | 8 | $130 |
| Amarin Pharma, Inc. | 8 | $129 |
| Radius Health, Inc. | 6 | $126 |
| Shire North American Group Inc | 6 | $100 |
| IBSA Pharma Inc. | 4 | $65 |
| AbbVie | 4 | $56 |
| Amryt Pharma Holdings Ltd | 3 | $46 |
| Jazz Pharmaceuticals Inc. | 3 | $38 |
| Johnson & Johnson | 3 | $38 |
| Currax Pharmaceuticals LLC | 2 | $25 |
| Vivus LLC | 1 | $24 |
| Lifescan, Inc. | 2 | $23 |
| BETA Bionics, Inc. | 1 | $18 |
| Senseonics, Incorporated | 1 | $16 |
| Nevro Corp. | 1 | $16 |
| Sequel Med Tech, LLC | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
| Companion Medical, Inc. | 1 | $12 |
How this compares
$54,852 in reported general payments places this provider in the 85th percentile of 312 endocrinology, diabetes & metabolism providers in Ohio.
See all endocrinology, diabetes & metabolism providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Columbus
- Elena ChristofidesColumbus$3.5M
- Steven IngColumbus$1.9M
- Kathleen DunganColumbus$1.4M
- Kyaw SoeColumbus$1.3M
- Samuel AndersonColumbus$556K
- Kathleen WyneColumbus$510K
- Luma GhalibColumbus$180K
- Ravi DhawaleColumbus$175K
- Lawrence KirschnerColumbus$142K
- Laura RyanColumbus$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.